Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2005
09/09/2005WO2004096144A3 Compositions and methods for induction of opioid receptors
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2841741A1 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005CA2599304A1 Cell targeting conjugates
09/09/2005CA2557588A1 Medicaments and methods for treating headache
09/09/2005CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/09/2005CA2557482A1 Target for b-cell disorders
09/09/2005CA2557136A1 Flavivirus vaccines
09/09/2005CA2557093A1 Cancerous disease modifying antibodies
09/09/2005CA2557091A1 Cancerous disease modifying antibodies
09/09/2005CA2556632A1 Egf receptor epitope peptides and uses thereof
09/09/2005CA2556557A1 Method of evaluating the therapeutic potential of a vaccine for mucosal administration
09/09/2005CA2556479A1 Methods and compositions comprising supramolecular constructs
09/09/2005CA2556436A1 Process for preparing anit-a.beta. antibody
09/09/2005CA2556025A1 Method of treating abnormal cell growth using c-met and m-tor inhibitors
09/09/2005CA2555714A1 Methods for preparing t-cells for cell therapy
09/09/2005CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005CA2555251A1 E.coli o157:h7 c1-1nh-binding protein and methods of use
09/09/2005CA2555105A1 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
09/09/2005CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands
09/08/2005US20050198694 Truncated fragments of alpha-synuclein in Lewy body disease
09/08/2005US20050197494 Methods of treating thrombotic diseases with von willebrand factor specific antibodies
09/08/2005US20050197314 Synergistic combination of immunostimulatory CpG oligonucleotides and the immunopotentiating cytokine Flt3 ligand; immunotherapy of tumors, viral infections; cancer vaccines
09/08/2005US20050197308 drug delivery devices having skin piercing segments comprising solid biodegradable reservoirs containing antigens
09/08/2005US20050197307 Antagonizing interaction between polynucleotide sequence 1 and interferon regulatory factor 1 (IRF 1); herpes virus infections
09/08/2005US20050197306 DNA vaccines encoding heat shock proteins
09/08/2005US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/08/2005US20050196807 Gene mining system and method
09/08/2005US20050196806 Prostate specific antigen oligoepitope peptide
09/08/2005US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders
09/08/2005US20050196793 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers
09/08/2005US20050196471 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
09/08/2005US20050196443 Pulsatile release compositions and methods for enhanced intestinal drug absorption
09/08/2005US20050196440 Mucoadhesive drug delivery devices and methods of making and using thereof
09/08/2005US20050196415 Protein-based Streptococcus pneumoniae vaccines
09/08/2005US20050196414 Polylysine positively charged backbone, oligoarginine branching group, hydroxypropylcellulose viscosity modifying agent; treat wrinkles, hyperhidrosis, neurologic pain, migraine headache, reducing muscle spasms, preventing or reducing acne
09/08/2005US20050196413 for inducing a mucosal Immunoglobin A immune response and a systemic Immunoglobin G immune response; storage stability
09/08/2005US20050196412 Vaccine; components, parts, fragments and derivatives, genetic sequences; development of diagnostic and therapeutic compositions for treatment and prophylaxis of AIDS and related disorders; attenuating pathogenic strains of HIV-1 by mutagenizing particular regions of the HIV-1 genome; low risk
09/08/2005US20050196411 Immunogenic HIV compositions and related methods
09/08/2005US20050196408 Stimulating an immune response in a primate utilizing bacterial adhesin proteins and/or imunogenic fragments
09/08/2005US20050196406 Which display a passenger polypeptide on the outer surface of a biological entity; displayed passenger polypeptide is capable of interacting or binding with a given ligand
09/08/2005US20050196405 Pneumococcal surface protein c (pspc), epitopic regions and strain selection thereof, and uses therefor
09/08/2005US20050196403 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
09/08/2005US20050196400 Production of chimeric mouse-human antibodies with specificity to human tumor antigens
09/08/2005US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG
09/08/2005US20050196397 Factor IX/factor IXa activating antibodies and antibody derivatives
09/08/2005US20050196396 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay;
09/08/2005US20050196395 Methods of modulating immunity
09/08/2005US20050196383 Novel adjuvant system reduces risk of toxic side effects; based on honey bee venom melittin; oligonucleotide complexed or covalently linked with immunostimulatory peptide; non toxic DNA and RNA sequences to stimulate reactions against specific antigens, without risk of systemic immunogenicity, toxicity
09/08/2005US20050196381 Lentivirus vector-based approaches for generating an immune response to HIV in humans
09/07/2005EP1571218A1 Animal immunocontraceptives expressed in plants and uses thereof
09/07/2005EP1571214A2 Immunogenic detoxified mutant toxin
09/07/2005EP1571211A1 Antibodies against lesion tissue
09/07/2005EP1570856A2 A vaccine composition comprising an immunoadjuvant compound consisting of a RHO GTPase family activator
09/07/2005EP1570272A2 Identification of agonistic autoantibodies
09/07/2005EP1570250A2 Screening, quantitation and identification of active ingredients in natural products
09/07/2005EP1570067A2 Methods and compositions for immunization against hiv
09/07/2005EP1570057A2 Autocrine growth factor receptor antibodies and methods
09/07/2005EP1570056A2 Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
09/07/2005EP1569958A2 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment
09/07/2005EP1569955A2 Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof
09/07/2005EP1569950A2 Plasmodium falciparum antigens and methods of use
09/07/2005EP1569690A1 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent
09/07/2005EP1569689A2 Combination il2/anti-her2-antibody therapy for cancers characterized by overexpression of the her2 receptor protein
09/07/2005EP1569688A1 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies
09/07/2005EP1569687A1 Coccidial vaccine and methods of making and using same
09/07/2005EP1569686A2 Transmucosal administration of aggregated antigens
09/07/2005EP1569685A2 Complement receptor 2 targeted complement modulators
09/07/2005EP1569680A2 Treatment of diabetes
09/07/2005EP1569679A1 Chaperonin 10 immunosuppression
09/07/2005EP1569675A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
09/07/2005EP1569674A2 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
09/07/2005EP1569515A2 Methods for vaccinating against malaria
09/07/2005EP1569514A2 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
09/07/2005EP1569509A1 Cryogenically protected viral delivery systems and related manufacture and use
09/07/2005EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins
09/07/2005CN1665933A Immunoconjugates for the treatment of tumours
09/07/2005CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
09/07/2005CN1665921A Adenovirus vectors for immunotherapy
09/07/2005CN1665835A DNA sequence and recombinant production of the grass pollen allergen Phl p4
09/07/2005CN1665834A Novel vaccination
09/07/2005CN1665565A GHRELIN-carrier conjugates
09/07/2005CN1665535A Perylenequinones for use with immunotherapy agents
09/07/2005CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics
09/07/2005CN1665532A Calicheamicin derivative-carrier conjugates
09/07/2005CN1665531A Cancer vaccines and methods of using the same
09/07/2005CN1665530A Immunogenic composition
09/07/2005CN1665529A Method to enhance an immune response of nucleic acid vaccination
09/07/2005CN1665528A Adjuvant viral particle
09/07/2005CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
09/07/2005CN1665523A Angio-immunotherapy
09/07/2005CN1665487A Liposomal vaccine
09/07/2005CN1665388A Sterilization, stabilization and preservation of functional biologics
09/07/2005CN1664100A Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof
09/07/2005CN1663613A Recombinant protein and recombinant gene capable of preventing and curing I type diabetes mellitus through immunity
09/07/2005CN1663612A Preparation method of natural antibody silkworm protein capable of preventing AIDS
09/07/2005CN1663611A Application of chitosan for preparing helicobacter pylorus vaccine adjuvant
09/07/2005CN1663603A Applications of tumor-placenta antigen protein and its DNA in tumor treatment
1 ... 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 ... 1823